CH691808A5 - (-)-(3R)-3-Methyl-4-{4-[4-(4-pyridyl)piperazin-1-y1]phenoxy}buttersäure als Inhibitor der zellulären Adhäsion. - Google Patents

(-)-(3R)-3-Methyl-4-{4-[4-(4-pyridyl)piperazin-1-y1]phenoxy}buttersäure als Inhibitor der zellulären Adhäsion. Download PDF

Info

Publication number
CH691808A5
CH691808A5 CH00224/97A CH22497A CH691808A5 CH 691808 A5 CH691808 A5 CH 691808A5 CH 00224/97 A CH00224/97 A CH 00224/97A CH 22497 A CH22497 A CH 22497A CH 691808 A5 CH691808 A5 CH 691808A5
Authority
CH
Switzerland
Prior art keywords
pharmaceutically acceptable
optically active
active compound
compound
ester
Prior art date
Application number
CH00224/97A
Other languages
German (de)
English (en)
Inventor
Stuart Dennett Mills
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/457,538 external-priority patent/US5652242A/en
Priority claimed from GBGB9518188.9A external-priority patent/GB9518188D0/en
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of CH691808A5 publication Critical patent/CH691808A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
CH00224/97A 1995-06-01 1996-05-28 (-)-(3R)-3-Methyl-4-{4-[4-(4-pyridyl)piperazin-1-y1]phenoxy}buttersäure als Inhibitor der zellulären Adhäsion. CH691808A5 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/457,538 US5652242A (en) 1993-03-29 1995-06-01 Heterocyclic derivatives
GBGB9518188.9A GB9518188D0 (en) 1995-09-07 1995-09-07 Optically active derivative

Publications (1)

Publication Number Publication Date
CH691808A5 true CH691808A5 (de) 2001-10-31

Family

ID=26307696

Family Applications (1)

Application Number Title Priority Date Filing Date
CH00224/97A CH691808A5 (de) 1995-06-01 1996-05-28 (-)-(3R)-3-Methyl-4-{4-[4-(4-pyridyl)piperazin-1-y1]phenoxy}buttersäure als Inhibitor der zellulären Adhäsion.

Country Status (31)

Country Link
EP (1) EP0796247A1 (ko)
JP (1) JP2885941B2 (ko)
KR (1) KR100245957B1 (ko)
AT (1) AT406675B (ko)
AU (1) AU710105B2 (ko)
BE (1) BE1009520A5 (ko)
BR (1) BR9606409A (ko)
CA (1) CA2194397A1 (ko)
CH (1) CH691808A5 (ko)
CZ (1) CZ26997A3 (ko)
DE (1) DE19680509T1 (ko)
DK (1) DK10697A (ko)
ES (1) ES2137886B1 (ko)
FI (1) FI970393A (ko)
GB (1) GB2304340B (ko)
GR (1) GR1002702B (ko)
HU (1) HUP9700274A3 (ko)
IE (1) IE960405A1 (ko)
IL (1) IL118477A0 (ko)
IT (1) IT1290839B1 (ko)
LU (1) LU90008B1 (ko)
MC (1) MC2418A1 (ko)
MX (1) MX9700379A (ko)
NL (1) NL1003243C2 (ko)
NO (1) NO307460B1 (ko)
NZ (1) NZ308597A (ko)
PL (1) PL318440A1 (ko)
SE (1) SE510812C2 (ko)
SK (1) SK13097A3 (ko)
TR (1) TR199700020T1 (ko)
WO (1) WO1996038416A1 (ko)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0100158A3 (en) * 1982-07-28 1985-03-27 The Upjohn Company (3-pyridinyl)heteroalkarylalkanols, alkanoic acids and esters
GB8609630D0 (en) * 1986-04-19 1986-05-21 Pfizer Ltd Anti-arrhythmia agents
GB9406144D0 (en) * 1993-03-29 1994-05-18 Zeneca Ltd Heterocyclic compounds
DK0691959T3 (da) * 1993-03-29 1999-04-26 Zeneca Ltd Heterocykliske derivater som blodpladeaggregations-inhibitorer

Also Published As

Publication number Publication date
TR199700020T1 (tr) 1997-04-22
AU710105B2 (en) 1999-09-16
ES2137886B1 (es) 2000-08-16
NL1003243C2 (nl) 1996-12-04
FI970393A0 (fi) 1997-01-30
ES2137886A1 (es) 1999-12-16
NZ308597A (en) 1998-11-25
HU9700274D0 (en) 1997-04-28
BE1009520A5 (fr) 1997-04-01
MX9700379A (es) 1997-04-30
AT406675B (de) 2000-07-25
EP0796247A1 (en) 1997-09-24
SE9700203L (sv) 1997-01-24
ATA900596A (de) 1999-12-15
KR100245957B1 (ko) 2000-04-01
NO970437D0 (no) 1997-01-31
HUP9700274A3 (en) 2000-02-28
IT1290839B1 (it) 1998-12-14
GB2304340B (en) 1998-07-29
CZ26997A3 (en) 1997-08-13
GB9627127D0 (en) 1997-02-19
BR9606409A (pt) 1997-09-30
SK13097A3 (en) 1997-08-06
AU5827296A (en) 1996-12-18
NO970437L (no) 1997-02-20
HUP9700274A2 (hu) 1999-06-28
IE960405A1 (en) 1996-12-11
IL118477A0 (en) 1996-09-12
JP2885941B2 (ja) 1999-04-26
ITMI961113A1 (it) 1997-12-01
JPH09512836A (ja) 1997-12-22
PL318440A1 (en) 1997-06-09
GB2304340A (en) 1997-03-19
MC2418A1 (fr) 1997-05-23
GR1002702B (el) 1997-05-22
DK10697A (da) 1997-04-01
DE19680509T1 (de) 1997-12-04
SE9700203D0 (sv) 1997-01-24
CA2194397A1 (en) 1996-12-05
NO307460B1 (no) 2000-04-10
WO1996038416A1 (en) 1996-12-05
SE510812C2 (sv) 1999-06-28
LU90008B1 (fr) 1997-04-16
FI970393A (fi) 1997-01-30
ITMI961113A0 (it) 1996-05-31
KR970704689A (ko) 1997-09-06

Similar Documents

Publication Publication Date Title
DE602004006431T2 (de) Derivate von n-äheteroaryl(piperidin-2-yl)methylübenzamid, verfahren zu deren herstellung und deren anwendung in therapeutika
EP0707006B1 (de) Aroyl-piperidin-Derivate
DE60036726T2 (de) Harnstoff derivate als entzündungshemmende mittel
JP3126183B2 (ja) 抗微生物剤、並びに置換２−シクロヘキサン−２−イル−アミン誘導体およびその製造法
DE2705025A1 (de) Xanthinderivate, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
DD273833A5 (de) N 9 - cyclopentylsubstituierte adeninderivate
DE10163992A1 (de) 4-Aryl-chinazoline
DE602004001864T2 (de) Verbindungen und methoden zur behandlung von proliferativen krankheiten, retinopathie und arthritis
DE102005001411A1 (de) Substituierte 4-Phenyltetrahydroisochinoline, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament, sowie sie enthaltendes Medikament
EP0483580A2 (de) 1-(2-Arylethyl)-Pyrrolidine
EP1124824B1 (de) Chromenon- und chromanonderivate als integrinhemmer
DE69815137T2 (de) Epoxybernsteinsäureamid-derivate
DE19615232A1 (de) Neue Carbamoylderivate und deren Verwendung als 5-HT ¶1¶¶A¶-Antagonisten
DE60209806T2 (de) 2-amino-thiazolinderivate und ihre verwendung als hemmstoffe der induzierbaren no-synthase
DE4430091A1 (de) Verwendung von N-substituierten Phenothiazinen
DE60129174T2 (de) Neue pleuromutilinderivate
US4933354A (en) 2-pyrrolidone-5-carboxylic acid compounds useful for the treatment of mental disorders
EP0725064A1 (de) Verwendung von Phenylcyclohexylcarbonsäureamiden
DE60206376T2 (de) Faktor xa inhibitor
DE102020103516B4 (de) Antivirale Wirkstoffe mit breiter Aktivität
CH691808A5 (de) (-)-(3R)-3-Methyl-4-{4-[4-(4-pyridyl)piperazin-1-y1]phenoxy}buttersäure als Inhibitor der zellulären Adhäsion.
DE3715763A1 (de) Diarylalkyl-substituierte alkylamine, verfahren zu ihrer herstellung, ihre verwendung sowie sie enthaltende arzneimittel
DE2305514A1 (de) Verfahren zur herstellung von lysergsaeureamiden und dihydrolysergsaeureamiden sowie lysergsaeureamide und dihydrolysergsaeureamide und ihre verwendung
EP0086453A2 (de) Thiazaspiranderivate, Verfahren zu ihrer Herstellung und Arzneimittel
DD153691A5 (de) Verfahren zur herstellung von hexahydro-trans-4a,9b-1(h)pyridoindol-derivaten

Legal Events

Date Code Title Description
PUE Assignment

Owner name: ZENECA LIMITED TRANSFER- ASTRAZENECA AB

PL Patent ceased